This is in contrast to the absence of the HLA-B*57:01 allele, which has an NPV of 100% for abacavir hypersensitivity (a reaction distinct from SJS/TEN, though illustrative as an example)
J.JaeschkeH
Just like we've seen with Cognizin citicoline, Setria For Sport stands as a testament to Kyowa Hakko's commitment to research-backed innovation, addressing multiple physiological pathways
Injectable photocrosslinking spherical hydrogel-encapsulated targeting peptide-modified engineered exosomes for osteoarthritis therapy
Effectiveness of monitoring free carnitine levels for L-carnitine supplementation in hemodialysis patients to maintain carnitine sufficiency and nutritional factors
Oral metabolic franchise, a broader portfolio of oral small molecule candidates targeting metabolic disease beyond the lead GLP-1 program Recent Highlights: In May 2026, Structure reported positive end-of-Phase 2 feedback from the FDA for aleniglipron, clearing the way to begin a Phase 3 registrational program for chronic weight management in Q3 2026